1.655
price up icon0.91%   0.015
 
loading
전일 마감가:
$1.64
열려 있는:
$1.62
하루 거래량:
124.12K
Relative Volume:
0.16
시가총액:
$87.70M
수익:
$139.77M
순이익/손실:
$-97.62M
주가수익비율:
-1.0475
EPS:
-1.58
순현금흐름:
$-61.71M
1주 성능:
+8.88%
1개월 성능:
+31.35%
6개월 성능:
-50.45%
1년 성능:
-88.83%
1일 변동 폭
Value
$1.58
$1.66
1주일 범위
Value
$1.57
$1.81
52주 변동 폭
Value
$0.9897
$16.44

Macrogenics Inc Stock (MGNX) Company Profile

Name
명칭
Macrogenics Inc
Name
전화
301-251-5172
Name
주소
9704 MEDICAL CENTER DRIVE, Rockville, MD
Name
직원
0
Name
트위터
@macrogenics
Name
다음 수익 날짜
2025-03-07
Name
최신 SEC 제출 서류
Name
MGNX's Discussions on Twitter

MGNX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
MGNX
Macrogenics Inc
1.655 87.70M 139.77M -97.62M -61.71M -1.58
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
501.81 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
568.09 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
629.64 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
259.07 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
248.21 24.70B 3.81B -644.79M -669.77M -6.24

Macrogenics Inc Stock (MGNX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-11-07 다운그레이드 JMP Securities Mkt Outperform → Mkt Perform
2024-08-01 다운그레이드 BTIG Research Buy → Neutral
2024-07-31 다운그레이드 B. Riley Securities Buy → Neutral
2024-07-31 다운그레이드 Guggenheim Buy → Neutral
2024-05-10 다운그레이드 BMO Capital Markets Outperform → Market Perform
2024-05-10 다운그레이드 Stifel Buy → Hold
2024-05-10 다운그레이드 TD Cowen Buy → Hold
2024-04-26 개시 B. Riley Securities Buy
2024-04-09 업그레이드 TD Cowen Hold → Buy
2024-03-04 재확인 BTIG Research Buy
2024-02-14 다운그레이드 H.C. Wainwright Buy → Neutral
2023-12-20 업그레이드 Citigroup Neutral → Buy
2023-11-07 업그레이드 Guggenheim Neutral → Buy
2023-03-17 다운그레이드 Guggenheim Buy → Neutral
2022-11-22 다운그레이드 Cowen Outperform → Market Perform
2022-11-14 업그레이드 BMO Capital Markets Market Perform → Outperform
2022-07-18 다운그레이드 SMBC Nikko Outperform → Neutral
2022-07-11 다운그레이드 BMO Capital Markets Outperform → Market Perform
2022-05-04 다운그레이드 Guggenheim Buy → Neutral
2022-02-28 업그레이드 Citigroup Neutral → Buy
2022-02-11 개시 BMO Capital Markets Outperform
2022-02-04 개시 SMBC Nikko Outperform
2021-11-17 재개 Guggenheim Buy
2021-10-19 개시 JMP Securities Mkt Outperform
2021-10-15 재개 BTIG Research Buy
2021-04-26 재개 Credit Suisse Outperform
2021-03-12 업그레이드 Barclays Underweight → Overweight
2020-12-22 재개 H.C. Wainwright Buy
2020-08-03 다운그레이드 Citigroup Buy → Neutral
2020-06-01 업그레이드 Guggenheim Neutral → Buy
2020-05-26 재확인 H.C. Wainwright Buy
2020-03-04 개시 Barclays Underweight
2019-12-19 개시 Cantor Fitzgerald Overweight
2019-12-18 개시 Cantor Fitzgerald Overweight
2019-11-21 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2019-11-20 재개 Guggenheim Neutral
2019-05-03 업그레이드 Wedbush Neutral → Outperform
2019-04-12 개시 Guggenheim Neutral
2019-02-07 업그레이드 Citigroup Sell → Buy
2019-02-07 다운그레이드 Wedbush Outperform → Neutral
2019-02-06 업그레이드 Raymond James Underperform → Mkt Perform
2019-02-04 다운그레이드 Citigroup Neutral → Sell
2018-12-10 다운그레이드 Raymond James Outperform → Underperform
2018-09-10 재개 BTIG Research Buy
2018-05-31 개시 Evercore ISI Outperform
2018-03-05 개시 H.C. Wainwright Buy
2017-03-31 개시 Raymond James Outperform
모두보기

Macrogenics Inc 주식(MGNX)의 최신 뉴스

pulisher
Apr 28, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 28, 2025
pulisher
Apr 23, 2025

MGNXMacroGenics Provides Update on Corporate Progress and 2024 Financial Results - ADVFN

Apr 23, 2025
pulisher
Apr 22, 2025

The MGNX Stock Puzzle: Unraveling Macrogenics Inc’s Fluctuating Performance - investchronicle.com

Apr 22, 2025
pulisher
Apr 21, 2025

MacroGenics Provides Update on Corporate Progress and 1st Quarter 2017 Financial Results - ADVFN

Apr 21, 2025
pulisher
Apr 21, 2025

MacroGenics Provides Update on Corporate Progress and 2024 Financial Results - ADVFN

Apr 21, 2025
pulisher
Apr 21, 2025

Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN

Apr 21, 2025
pulisher
Apr 21, 2025

MacroGenics Provides Update on Corporate Progress and First Quarter 2019 Financial Results - ADVFN

Apr 21, 2025
pulisher
Apr 20, 2025

MacroGenics Provides Update on Corporate Progress and Third Quarter 2021 Financial Results - ADVFN

Apr 20, 2025
pulisher
Apr 20, 2025

MacroGenics Provides Update on Corporate Progress and Third Quarter 2015 Financial Results - ADVFN

Apr 20, 2025
pulisher
Apr 20, 2025

Investor Expectations to Drive Momentum within LPL Financial, Comcast, MacroGenics, Wayfair, Masimo, and Big Lots — Discove... - ADVFN

Apr 20, 2025
pulisher
Apr 20, 2025

MacroGenics Provides Update on Corporate Progress and Second Quarter 2019 Financial Results - ADVFN

Apr 20, 2025
pulisher
Apr 20, 2025

MacroGenics Provides Update on Corporate Progress and Second Quarter 2023 Financial Results - ADVFN

Apr 20, 2025
pulisher
Apr 20, 2025

MacroGenics Provides Update on Corporate Progress and Second Quarter 2021 Financial Results - ADVFN

Apr 20, 2025
pulisher
Apr 20, 2025

Comparing Ensysce Biosciences (NASDAQ:ENSC) & MacroGenics (NASDAQ:MGNX) - Defense World

Apr 20, 2025
pulisher
Apr 19, 2025

MacroGenics, Inc. (NASDAQ:MGNX) Receives $7.38 Average Price Target from Analysts - Defense World

Apr 19, 2025
pulisher
Apr 18, 2025

MacroGenics, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsMGNX - marketscreener.com

Apr 18, 2025
pulisher
Apr 15, 2025

American Century Companies Inc. Buys Shares of 11,743 MacroGenics, Inc. (NASDAQ:MGNX) - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

MacroGenics, Inc. (NASDAQ:MGNX) Looks Inexpensive After Falling 42% But Perhaps Not Attractive Enough - simplywall.st

Apr 14, 2025
pulisher
Apr 14, 2025

Wellington Management Group LLP Acquires 16,717 Shares of MacroGenics, Inc. (NASDAQ:MGNX) - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

ATTENTION MGNX SHAREHOLDERS: Investors who lost money on MacroGenics, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation - ACCESS Newswire

Apr 13, 2025
pulisher
Apr 11, 2025

Next Generation Immunotherapies Market Growth Projections - openPR.com

Apr 11, 2025
pulisher
Apr 11, 2025

MGNX Deadline in 5 Days: Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc. (MGNX) Investors of Filing Deadline in Class Action Lawsuit - marketscreener.com

Apr 11, 2025
pulisher
Apr 10, 2025

Class Action Filed Against MacroGenics, Inc. (MGNX) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 10, 2025

MGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MacroGenics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 10, 2025

MGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MacroGenics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 10, 2025

MGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MacroGenics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 10, 2025

Lost Money on MacroGenics, Inc.(MGNX)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire

Apr 10, 2025
pulisher
Apr 10, 2025

908 Devices Leads These 3 Penny Stocks To Consider - simplywall.st

Apr 10, 2025
pulisher
Apr 09, 2025

MGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MacroGenics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 09, 2025
pulisher
Apr 08, 2025

ATTENTION MacroGenics, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire

Apr 08, 2025
pulisher
Apr 08, 2025

Levi & Korsinsky Notifies Shareholders of MacroGenics, Inc. (MGNX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Apr 08, 2025
pulisher
Apr 08, 2025

MacroGenics (MGNX) Halts Prostate Cancer Trial After Fatal Adverse Events, Investor SuitHagens Berman - ACCESS Newswire

Apr 08, 2025
pulisher
Apr 06, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics, Inc. LawsuitMGNX - ACCESS Newswire

Apr 06, 2025
pulisher
Apr 03, 2025

MacroGenics (MGNX) Loses -48.74% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Apr 03, 2025
pulisher
Apr 03, 2025

Levi & Korsinsky Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, 2024MGNX - ACCESS Newswire

Apr 03, 2025
pulisher
Mar 30, 2025

MacroGenics, Inc. (NASDAQ:MGNX) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

Bank of New York Mellon Corp Has $540,000 Stock Holdings in MacroGenics, Inc. (NASDAQ:MGNX) - Defense World

Mar 28, 2025

Macrogenics Inc (MGNX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Macrogenics Inc 주식 (MGNX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Karrels James
SVP, CFO and Secretary
Feb 15 '25
Option Exercise
0.00
14,998
0
192,591
Koenig Scott
President and CEO
Feb 15 '25
Option Exercise
0.00
42,329
0
777,415
Peters Jeffrey Stuart
Senior VP and General Counsel
Feb 15 '25
Option Exercise
0.00
13,332
0
18,858
Risser Eric Blasius
Chief Operating Officer
Feb 15 '25
Option Exercise
0.00
16,665
0
62,422
Smith Beth Ann
VP, Controller & Treasurer
Feb 15 '25
Option Exercise
0.00
1,095
0
9,955
Smith Beth Ann
VP, Controller & Treasurer
Feb 15 '25
Sale
2.56
423
1,083
9,532
Spitznagel Thomas
Sr VP, Technical Ops
Feb 15 '25
Option Exercise
0.00
13,332
0
26,922
Eck Stephen L.
Chief Medical Officer
Feb 15 '25
Option Exercise
0.00
16,665
0
34,319
Eck Stephen L.
Chief Medical Officer
Feb 08 '25
Option Exercise
0.00
11,168
0
20,966
SIEGEL JAY PHILIP
Director
May 20 '24
Option Exercise
0.00
4,500
0
4,500
$20.90
price up icon 1.36%
$69.80
price up icon 0.31%
$32.42
price down icon 0.60%
$24.00
price up icon 0.25%
$103.85
price down icon 0.51%
biotechnology ONC
$249.09
price down icon 0.47%
자본화:     |  볼륨(24시간):